AB 26. Comparison of pharmacokinetics of Moxifloxacin between patients with drug-resistant and multi-drug resistant pulmonary tuberculosis

BACKGROUND: Moxifloxacin is a potent bactericidal and sterilizing antitubercular drug that is currently used as part of the therapeutic regimen in cases of drug resistant (DR) and multi-drug resistant (MDR) tuberculosis (TB). According to previous reports rifampicin reduces Moxifloxacin levels by 30...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Manika, Katerina, Chatzika, Kalliopi, Papaioannou, Maria, Kontou, Paschalina, Zarogoulidis, Konstantinos, Kioumis, Ioannis
Format: Artigo
Idioma:Inglês
Publicat: Pioneer Bioscience Publishing Company 2012
Matèries:
Abstract
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3537437/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2012.s026
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars